Our in silico optimization platform, StarDrop,  is an interactive platform which enables scientists to efficiently design, profile, identify and effectively prioritize compounds to achieve an optimal balance of properties at all stages of drug discovery. This intuitive desktop interface integrates predicted and experimental data, such as potency and selectivity measurements, enabling scientists to rapidly identify and design high quality compounds to meet their project’s objectives.

In July 2008, BioFocus DPI announced the transfer of its predictive drug discovery databases to the European Bioinformatics Institute (EMBL-EBI), who will make these databases publicly available on-line to drug discovery researchers worldwide (view press release).  Databases included under the agreement are: DrugStore™ (database of known drugs), StARLITe™ (database of known compounds and their effects), Strudle™ (binding site drugability), and Kinase SARfari™ and GPCR SARfari™ (informatics systems for the most widely used target classes in drug discovery).  Please visit the EBI website for more information about accessing these databases.  StarDrop is not part of this transaction and will continue to be offered by BioFocus DPI.